NCT03424746View on ClinicalTrials.gov

Chelation Therapy in Diabetic Patients With Critical Limb Ischemia

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

February 18, 2019

Conditions
Critical Limb IschemiaPeripheral Arterial Disease
Interventions
DRUG

disodium EDTA

Open-label study of TACT-formula, EDTA-based chelation therapy + commercially available TACT oral multi vitamins, delivering 40-50 infusions over 1 year.

Trial Locations (1)

33140

Mount Sinai Medical Center, Miami Beach

All Listed Sponsors
lead

Mt. Sinai Medical Center, Miami

OTHER

NCT03424746 - Chelation Therapy in Diabetic Patients With Critical Limb Ischemia | Biotech Hunter | Biotech Hunter